COVID19 impact on the Indian API market
Loading player...
Investec India hosted Mr Mahesh Doshi (IDMA National President & Promoter of an API Manufacturing Co) recently to discuss impact of COVID19 and lockdown on the API market. Mr Doshi spoke about the challenges faced by the drug manufacturers in the past few days particularly in transportation due to lack of migrant labourers, how to counter China’s dominance in the API market.
Mr. Doshi has 30+ years of experience in the pharma industry. Along with being the national president of the Indian Drugs Manufacturers Association (IDMA), he also runs his own API manufacturing company named Dy-Mach Pharma which has manufacturing plants in Vapi (Gujarat).
Mr. Doshi has 30+ years of experience in the pharma industry. Along with being the national president of the Indian Drugs Manufacturers Association (IDMA), he also runs his own API manufacturing company named Dy-Mach Pharma which has manufacturing plants in Vapi (Gujarat).
